Danaher Overview

  • Founded
  • 1969
Founded
  • Status
  • Public
  • Employees
  • 60,000
Employees
  • Stock Symbol
  • DHR
Stock Symbol
  • Investments
  • 75
  • Share Price
  • $223.83
  • (As of Monday Closing)

Danaher General Information

Description

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which adds to its life sciences segment.

Contact Information

Website
Formerly Known As
Diversified Mortgage Investors, DMG
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Medical Supplies
Environmental Services (B2B)
Stock Exchange
NYS
Primary Office
  • 2200 Pennsylvania Avenue, North West
  • Suite 800 West
  • Washington, DC 20037
  • United States
+1 (202) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Danaher Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$223.83 $227.45 $119.60 - $229.45 $159B 709M 2.01M $4.74

Danaher Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 148,489,342 112,369,328 82,130,487 74,831,680
Revenue 17,515,100 17,911,100 17,048,500 15,518,800
EBITDA 5,020,300 4,464,400 4,267,300 3,792,700
Net Income 3,465,500 3,008,200 2,650,900 2,492,100
Total Assets 71,268,400 62,081,600 47,832,500 46,648,600
Total Debt 22,387,200 22,526,000 9,740,300 10,522,100
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Danaher Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Danaher‘s full profile, request access.

Request a free trial

Danaher Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Thr
Holding Companies
Washington, DC
60,000 As of 2019
00000000

0000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
0000000000 000000000 000 00000000000
Everett, WA
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Danaher Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Corporate Backed or Acquired Everett, WA 00000 00000000
To view Danaher’s complete competitors history, request access »

Danaher Executive Team (70)

Name Title Board Seat Contact Info
Rainer Blair Chief Executive Officer, President & Board Member
Matthew McGrew Chief Financial Officer, Finance & Executive Vice President
Michael Egholm Ph.D Chief Technology Officer, Danaher Life Sciences
Philip Whitehead Chairman European Board & Corporate officer and Corporate Development EU
Robert Lutz Chief Accounting Officer, Accounting & Senior Vice President
You’re viewing 5 of 70 executive team members. Get the full list »

Danaher Board Members (10)

Name Representing Role Since
0000 00000 00 Self Board Member 000 0000
000000 0000000 00. Self Board Member 000 0000
00000 00000000 00 Self Board Member 000 0000
00000 000000 Danaher Board Member 000 0000
00000000 00000 Self Founder & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Danaher Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Danaher Investments & Acquisitions (75)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000 29-Jul-2020 00000 00000 00 0000 Biotechnology
000000 000 0000000 26-Jun-2020 000000000 Other Pharmaceuticals and Biotechnology
000000 31-Mar-2020 000000000000000000 000.00 Other Devices and Supplies
0000000000 000 000 13-Apr-2018 000000000000000000 00.00 Specialty Chemicals 000000 00000 00.
ID Business Solutions 30-Oct-2017 Merger/Acquisition Other Information Technology 000000 00000
You’re viewing 5 of 75 investments and acquisitions. Get the full list »

Danaher Subsidiaries (30)

Company Name Industry Location Founded
Cepheid Diagnostic Equipment Sunnyvale, CA 1996
000000 Other Healthcare Oxnard, CA 0000
0000000 00000000 0 Diagnostic Equipment Hatfield, PA 0000
00000000 000000 00 Industrial Supplies and Parts Hod Hasharon, Israel 0000
0000000000 0000000 Electrical Equipment Petah Tikva, Israel 0000
You’re viewing 5 of 30 subsidiaries. Get the full list »

Danaher Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000 00000 06-Jul-2010 00000 0000000 Completed
  • 2 buyers
000000000 21-Nov-2007 000000000000000000 00.00 Completed
  • 0000000
00000000 000000000 21-Sep-2004 00000 00000 00 000.00 Completed
  • 3 buyers
00000000 00000000 01-Mar-2004 000000000000000000 Completed
  • 0000000
Solution Net Systems 21-Nov-2003 Merger/Acquisition 0000 Completed
You’re viewing 5 of 10 exits. Get the full list »